5-CHLORO-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-2-AMINE, 97.0%, 5g

1-TERT-BUTYL 2-ETHYL 5-OXOPYRROLIDINE-1,2-DICARBOXYLATE, 95%, 5g

4-Bromo-3,5-dimethyl-benzonitrile, 99.00%, 10g

Quinoxaline-2,3-diamine, 97.0%, 100mg

2-[2-(2-methoxyethoxy)ethoxy]-ethanethiol, 98%, 10g

4,5-dihydroxy-2-pyridinecarboxylic acid hydrate, 95.0%, 5g

(4-Fluorophenyl)(4-hydroxyphenyl)methanone, 95.0%, 25g

1-(4-Chlorophenyl)-3-methyl-1H-thieno[2,3-c]pyrazole-5-carboxylic acid, 97%, 50mg

(6-((1-(tert-Butyl)-1H-pyrazol-5-yl)amino)pyrazin-2-yl)methanol, 95+%, 1g

Accessories exchange block for reaction vessels, Gesch. for, 24 reaction vials 2.0 ml, 1 piece

1,4,5,6-tetrahydrocyclopenta[c]pyrazole, 95.0%, 250mg

2-Hydroxy-6-methyl-3-nitropyridine, 95.0%, 10g

5H-Dibenzo[b,f]azepine-5-carboxamide, 95.0%, 25g